Philadelphia, PA – Neuralert Technologies LLC (www.neuralerttechnologies.com) has been selected to participate in the Fall 2020 NextFab Studio LLC RAPID Hardware Accelerator program. NextFab is a pre-seed stage hardware-focused investor and a network of makerspaces in the Greater Philadelphia area.
Neuralert is a spin-out from the University of Pennsylvania, founded by Steven Messe, MD (Department of Neurology) and James Weimer, PhD (Department of Computer and Information Science). The company focuses on early detection of stroke symptoms in hospitalized patients via smart, non-invasive, wearable devices. Its innovative platform can accurately detect these symptoms and immediately alert clinical staff to assess the patient and initiate stroke mitigating treatments. Neuralert dramatically reduces the time to detect stroke symptoms, saving patient lives, improving outcomes and reducing hospital costs and liability.
As part of the RAPID Accelerator’s Fall 2020 cohort, Neuralert will receive hands-on technical product development support, seed capital, business coaching, and access to manufacturing and prototyping equipment at NextFab.
“We believe we can end the devastation caused by in-hospital strokes. Using an automated method like Neuralert to monitor post-surgical patients as well as patients with elevated stroke risk, decreases the delay between a stroke event and treatment” said Eric Corkhill, CEO of Neuralert Technologies. “NextFab will help us to create purpose-built, wearable devices designed to operate within the complexities of the clinical environment while ensuring high adoption by both patients and staff”.